Glucocorticoid- and Transplantation-Induced Osteoporosis
| Autor: | Guido Zavatta, Bart L. Clarke |
|---|---|
| Přispěvatelé: | Zavatta, Guido, Clarke, Bart L |
| Rok vydání: | 2021 |
| Předmět: |
Endocrinology
Diabetes and Metabolism Osteoporosis 030209 endocrinology & metabolism Bioinformatics 03 medical and health sciences Glucocorticoid 0302 clinical medicine Endocrinology Bone Density BMD medicine Humans Corticosteroid Glucocorticoids business.industry Osteoporosi medicine.disease Treatment Transplantation Fracture 030220 oncology & carcinogenesis Glucocorticoid-induced osteoporosi Transplant-induced osteoporosi Secondary osteoporosis business medicine.drug |
| Zdroj: | Endocrinology and Metabolism Clinics of North America. 50:251-273 |
| ISSN: | 0889-8529 |
| Popis: | Glucocorticoid-induced osteoporosis is the most common cause of secondary osteoporosis; nonetheless, it remains an undertreated condition. Transplantation-induced osteoporosis encompasses a broad range of unique pathogenetic features with distinct characteristics dependent on the transplanted organ. Understanding the pathogenesis of bone loss is key to recommending osteoporosis therapy in these patients. This review summarizes recent advances and addresses current issues in these fields. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|